Based on the ProShares Ultra Health Care stock forecast from 0 analysts, the average analyst target price for ProShares Ultra Health Care is not available over the next 12 months. ProShares Ultra Health Care’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ProShares Ultra Health Care is Neutral, which is based on 2 positive signals and 2 negative signals. At the last closing, ProShares Ultra Health Care’s stock price was USD 100.78. ProShares Ultra Health Care’s stock price has changed by -2.92% over the past week, -6.98% over the past month and -84.32% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for RXL !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
